⌘K

Login Start Free

Home/Filings/4/0001569706-18-000001

4//SEC Filing

LANHAM RANDALL J 4

Accession 0001569706-18-000001

CIK 0001018735other

View on SEC.gov Company Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:20 PM ET

Size

4.2 KB

Accession

0001569706-18-000001

Insider Transaction Report

Form 4

Period: 2018-10-28

NYMOX PHARMACEUTICAL CORPNYMX

LANHAM RANDALL J

DirectorGeneral Counsel

Transactions

Purchase
Common
2018-10-28$1.72/sh+2,900$4,988→ 152,900 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

NYMOX PHARMACEUTICAL CORP

CIK 0001018735

Entity typeother

Related Parties

1

filerCIK 0001278724

Filing Metadata

Form type: 4
Filed: Nov 5, 7:00 PM ET
Accepted: Nov 6, 5:20 PM ET
Size: 4.2 KB

View on SEC.gov